PQ 307
307. Deputy Kate O'Connell asked the Minister for Health if an independent expert to review the appropriateness, transparency and timeliness of the HSE's reimbursement process for orphan medicinal drugs will be appointed in view of a growing number of orphan drugs failing to secure reimbursement here despite being made available in other EU countries; and if he will make a statement on the matter. [52839/17]
Introduced
12 December 2017
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
12 December 2017
Summary
307. Deputy Kate O'Connell asked the Minister for Health if an independent expert to review the appropriateness, transparency and timeliness of the HSE's reimbursement process for orphan medicinal drugs will be appointed in view of a growing number of orphan drugs failing to secure reimbursement here despite being made available in other EU countries; and if he will make a statement on the matter. [52839/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Reimbursement
Medicinal Products Reimbursement
xml · EN · 12 December 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-12-12/307/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-12-12/pq_307